These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37966436)

  • 1. [Pharmacotherapy approaches to vascular mild cognitive impairment in patients of different age groups].
    Zakharov VV; Fedin AI; Mhitaryan EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(10):26-32. PubMed ID: 37966436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)].
    Zakharov VV; Tkacheva ON; Mkhitaryan EA; Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):73-80. PubMed ID: 36412160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
    Fedin AI; Zakharov VV; Tanashyan MM; Chukanova EI; Madzhidova EN; Shchepankevich LA; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):7-16. PubMed ID: 34932280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Features of pharmacotherapy of vascular cognitive impairment in the elderly].
    Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(9):15-20. PubMed ID: 37796062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
    Chukanova EI; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of oxidative stress in the development of vascular cognitive disorders].
    Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):133-139. PubMed ID: 32929936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Kutashov VA; Ulyanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A modern concept of antihypoxic and antioxidant effects of mexidol].
    Shchulkin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12. Vyp. 2):87-93. PubMed ID: 30830123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis].
    Vizilo TL; Arefieva EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
    Stakhovskaya LV; Shamalov NA; Khasanova DR; Melnikova EV; Agafiina AS; Golikov KV; Bogdanov EI; Yakupova AA; Roshkovskaya LV; Lukinykh LV; Lokshtanova TM; Poverennova IE; Shepankevich LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):55-65. PubMed ID: 28665371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.
    Cotroneo AM; Castagna A; Putignano S; Lacava R; Fantò F; Monteleone F; Rocca F; Malara A; Gareri P
    Clin Interv Aging; 2013; 8():131-7. PubMed ID: 23403474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
    Guekht A; Skoog I; Edmundson S; Zakharov V; Korczyn AD
    Stroke; 2017 May; 48(5):1262-1270. PubMed ID: 28432265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
    Zhuravleva MV; Kamchatnov PR; Vasyukova NS; Arkhipov VV; Kuznetsova EV; Kameneva TR; Serebrova SY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):29-39. PubMed ID: 36440774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
    Abramenko IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia].
    Shchepankevich LA; Nikolaev YA; Taneeva EV; Pervuninskaya MA; Shchepankevich MS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):32-37. PubMed ID: 34874652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypoxic and antinecrotic effect of mexidol in skin ischemia.
    Galenko-Yaroshevskii VP; Bagmetova EN; Fil'chukova IA; Sidel'nikov AY; Popkov VA; Gorelashvili AS; Antelava NA; Sukoyan GV
    Bull Exp Biol Med; 2005 Feb; 139(2):202-6. PubMed ID: 16027807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Divaza for the Correction of Oxidative Disturbances in Patients with Cerebral Atherosclerosis: A Randomized Controlled Trial.
    Lashch NU; Kamchatnov PR; Fedorova TN; Muzychuk OA; Khacheva KK; Pizova NV; Malygin AU; Shavlovskaya OA; Fateeva VV; Nikulina KV; Abrosimov АV; Gerasimova YA; Glushkov KS; Lebedeva AV
    Cerebrovasc Dis; 2021; 50(4):472-482. PubMed ID: 34044407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Abramenko YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and safety of mexidol forte 250 in the sequential therapy in patients with chronic ischemia].
    Kataeva NG; Zamoshchina TA; Svetlik MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):59-63. PubMed ID: 33340299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Fujino T; Yamada T; Asada T; Tsuboi Y; Wakana C; Mawatari S; Kono S
    EBioMedicine; 2017 Mar; 17():199-205. PubMed ID: 28259590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.